This company seems to have been delisted
Reason: Acquired by Baxter
Source: https://www.baxter.com/baxter-newsroom/baxter-completes-acquisition-hillrom-creating-15-billion-global-medtech-leader
Reason: Acquired by Baxter
Source: https://www.baxter.com/baxter-newsroom/baxter-completes-acquisition-hillrom-creating-15-billion-global-medtech-leader
Hill-Rom
HRC
₹13,301
Share price
0.03%
Change (1 day)
16,536.30%
Change (1 year)
Categories
Hillrom or Hill-Rom is an American medical device provider.
Revenue for Hill-Rom (HRC)
Revenue in 2021 (TTM): ₹222.78 Billion
According to Hill-Rom's latest financial reports the company's current revenue is ₹257.44 Billion. In 2020 the company made a revenue of ₹250.49 Billion an increase over the revenue in the year 2019 that were of ₹248.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hill-Rom from 2003 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | ₹222.78 B | -11.06% |
| 2020 | ₹250.49 B | 0.97% |
| 2019 | ₹248.07 B | 1.64% |
| 2018 | ₹244.06 B | 3.09% |
| 2017 | ₹236.75 B | 5.5% |
| 2016 | ₹224.41 B | 20.46% |
| 2015 | ₹186.29 B | 24.28% |
| 2014 | ₹149.90 B | 4.55% |
| 2013 | ₹143.38 B | -0.02% |
| 2012 | ₹143.41 B | 5.19% |
| 2011 | ₹136.33 B | 7.4% |
| 2010 | ₹126.94 B | 7.04% |
| 2009 | ₹118.59 B | -8.39% |
| 2008 | ₹129.45 B | -25.77% |
| 2007 | ₹174.39 B | 3.87% |
| 2006 | ₹167.89 B | 1.37% |
| 2005 | ₹165.62 B | 3.19% |
| 2004 | ₹160.50 B | -10.34% |
| 2003 | ₹179.01 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | ₹1.927 T | 648.50% | 🇺🇸 USA |
 | ₹434.53 B | 68.79% | 🇮🇪 Ireland |
 | ₹18.946 T | 7,259.46% | 🇺🇸 USA |
 | ₹3.905 T | 1,417.18% | 🇺🇸 USA |